Low C reactive protein-alleles in hepatocyte nuclear factor 1A are associated with an increased risk of cardiovascular disease: a Meta-analysis.

Published in: The Journal of clinical endocrinology and metabolism (2024)

Our study revealed an association between low CRP-alleles in HNF1A and a high CVD risk, which indicated that anti-diabetic drugs with cardiovascular benefits such as GLP-1 receptor agonist should be recommended as first-line choice for HNF1A-MODY.

Keyphrases

nuclear factor
toll like receptor
cardiovascular disease
type diabetes
immune response
metabolic syndrome
wound healing
cardiovascular events
breast cancer risk